BioSpace News Archive

AGC Biologics adds leading-edge cell & gene therapy company in Milan, Italy

The combination of real-life data sets in rare diseases with innovative big data/artificial intelligence/novel scientific computational knowledge will transform biomedical research, product development, and therapy. R eal-life data and I nnovative B ioinformatic A lgorithms (RIBA project) will enable the creation of a powerful environment to accelerate, de-risk, and improve the development of new orphan drugs for many diseases and disease areas. RIBA develops and offers data-/computing-dri

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will release its second quarter 2020 financial results on Thursday, August 6, 2020. Insmed management will host a conference call for investors beginning at

Lynk Pharmaceuticals is pleased to announce exclusive licensing agreements with Kobe University and with RIKEN Research Institute to develop RAS inhibitors with a novel MOA.

Stratus™ Medical announced FDA clearance for the Vesta RF Cannula for use in radiofrequency heat lesion procedures for the relief of pain and first Vesta patient treatments in the United States.

Company extends program benefits to oncology laboratories and fast-tracks access to comprehensive molecular profiling on the Genexus System

UCB’s resilient product portfolio drives continued company growth

Castle Biosciences, Inc., a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, announced that it will release its financial results for the second quarter ended June 30, 2020, after the close of market on Monday, August 10, 2020.

Acceleron Pharma Inc. announced it will host a webcast and conference call on Thursday, August 6, 2020 at 5:00 p.m. EDT to discuss its second quarter 2020 operating and financial results.

Orthofix Medical Inc., a global medical device company focused on musculoskeletal products and therapies, announced that it plans to release financial results for the second quarter 2020 before market open on Thursday, August 6, 2020. Jon Serbousek, President and Chief Executive Officer, and Doug Rice, Chief Financial Officer, will host a conference call and webcast to review the Company’s results at 8:30 a.m.